-
2024-512012-21-00
5
2021-04-08
Chronic Obstructive Pulmonary Disease
-
2023-504990-19-00
5
2021-04-06
Agitation in Patients With Dementia of the Alzheimer's Type
-
2024-512013-41-00
5
2021-03-22
Chronic Obstructive Pulmonary Disease
-
2024-514495-41-00
5
2020-11-04
Primary Progressive Multiple Sclerosis
-
2022-501987-16-00
5
2020-10-02
Metastatic nonsquamous or squamous non-small cell lung cancer
-
2023-504207-89-00
5
2020-03-27
Retinopathy of prematurity
-
2022-501018-78-00
5
2020-03-23
Axial Spondyloarthritis
-
2022-502380-37-00
5
2019-08-02
Open-Angle Glaucoma
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2023-509304-16-00
5
2019-05-16
Pulmonary arterial hypertension (PAH)
-
2024-512352-38-00
4
2019-03-28
Hepatitis B, Chronic
-
2022-502936-38-00
5
2019-01-09
Moderate and Severe Atopic Dermatitis
-
2024-511553-22-00
5
2018-10-05
Moderately to Severely Active Crohn's Disease
-
2023-506543-41-00
5
2018-07-25
Multiple sclerosis (MS)
-
2022-500251-22-00
4
2018-04-12
This study will include all patients having received at least one infu
-
2024-513919-27-00
5
2017-09-14
Rheumatoid arthritis
-
2022-501353-37-00
5
Reversal of anticoagulation effect in patients on a FXa inhibitor (api
-
2023-507207-66-00
5
Diabetic Macular Edema (DME)
-
2023-508706-23-00
9
Non-Cystic Fibrosis Bronchiectasis with Pseudomonas Aeruginosa or othe
-
2023-509027-41-00
3
Hepatitis B, Chronic
-
2023-509206-29-00
5
Neovascular age-related macular degeneration (nAMD)
-
2023-509766-37-00
5
NSCLC
-
2024-511051-18-00
3
chronic hepatitis B virus infection (cHBV)
-
2024-512417-41-00
5
Osteoporosis